NO912804L - Purinderivater. - Google Patents

Purinderivater.

Info

Publication number
NO912804L
NO912804L NO91912804A NO912804A NO912804L NO 912804 L NO912804 L NO 912804L NO 91912804 A NO91912804 A NO 91912804A NO 912804 A NO912804 A NO 912804A NO 912804 L NO912804 L NO 912804L
Authority
NO
Norway
Prior art keywords
purine derivatives
purine
derivatives
Prior art date
Application number
NO91912804A
Other languages
English (en)
Norwegian (no)
Other versions
NO912804D0 (no
Inventor
Roland Jaunin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO912804D0 publication Critical patent/NO912804D0/no
Publication of NO912804L publication Critical patent/NO912804L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91912804A 1990-07-18 1991-07-17 Purinderivater. NO912804L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (2)

Publication Number Publication Date
NO912804D0 NO912804D0 (no) 1991-07-17
NO912804L true NO912804L (no) 1992-01-20

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912804A NO912804L (no) 1990-07-18 1991-07-17 Purinderivater.

Country Status (13)

Country Link
EP (1) EP0467207A3 (fr)
JP (1) JPH04234391A (fr)
KR (1) KR920002600A (fr)
AU (1) AU8038491A (fr)
CA (1) CA2044806A1 (fr)
FI (1) FI913407A7 (fr)
HU (1) HU209591B (fr)
IE (1) IE912500A1 (fr)
IL (1) IL98812A0 (fr)
MC (1) MC2278A1 (fr)
NO (1) NO912804L (fr)
PT (1) PT98348A (fr)
ZA (1) ZA915418B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (fr) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (es) 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
EP2527360B1 (fr) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
EP3241839B1 (fr) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (fr) * 1986-07-11 1995-01-24 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
JPH04234391A (ja) 1992-08-24
ZA915418B (en) 1992-03-25
HU209591B (en) 1994-08-29
NO912804D0 (no) 1991-07-17
FI913407A0 (fi) 1991-07-15
IL98812A0 (en) 1992-07-15
EP0467207A2 (fr) 1992-01-22
CA2044806A1 (fr) 1992-01-19
AU8038491A (en) 1992-01-23
EP0467207A3 (en) 1992-08-12
HUT58736A (en) 1992-03-30
FI913407A7 (fi) 1992-01-19
HU912347D0 (en) 1991-12-30
IE912500A1 (en) 1992-01-29
PT98348A (pt) 1992-05-29
KR920002600A (ko) 1992-02-28
MC2278A1 (fr) 1993-06-23

Similar Documents

Publication Publication Date Title
FI915487L (fi) 4-bensoylisoxazolderivat.
FI915736A7 (fi) A-oxoacetamidderivat.
NO910368L (no) Triazol-derivater.
NL300250I2 (nl) Chinuclidinederivaten.
FI912199A7 (fi) Baeraemne omfattande till strukturen integrerat anslutande baerhandtag.
DE69110254D1 (de) Hydroxychinolonderivate.
FI913142L (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
FI911776A7 (fi) Benzimidazolinonederivat.
FI911942L (fi) Kolhydratderivat innehaollande en trisackaridenhet.
ATE115560T1 (de) Acetamidderivate.
FI912376A7 (fi) Antivirala aemnen.
FI912598L (fi) Dioxo-tetrahydrokinolinderivat.
DE69110093D1 (de) Pyrimidinderivate.
NO912804D0 (no) Purinderivater.
FI922014L (fi) Nukleosidderivat.
NO884830L (no) Purin-derivater.
FI920394L (fi) 3-kinuklidinderivat.
FI900873A7 (fi) Foerfarande i samband med impedansgivare i radiosonder.
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
FI913763L (fi) Foerbaettringar till tobaksprodukter.
FI910897L (fi) Foerbaettringar roerande (s)-norfluoxetin.
FI912361A0 (fi) Kablingsmaskin foer s/z-kabling.
DE69004844D1 (de) Pyrimidin-Derivate.
FI912513L (fi) Syntes av nukleotid- och nukleosidderivat.
FI910654A0 (fi) Foervarings- och dispenseringsanordning foer till en cylindrisk foerpackning rullade flexibla plastpaosar.